Postmenopausal women who report high levels of physical activity are at reduced risk of developing breast cancer, especially estrogen receptor-positive/progesterone receptor-negative tumors (ER+/PR-), than women who are less active, according to data from the Iowa Women's Health Study published in the Dec. 11/25 issue of the Archives of Internal Medicine.
Postmenopausal women who report high levels of physical activity are at reduced risk of developing breast cancer, especially estrogen receptor-positive/progesterone receptor-negative tumors (ER+/PR-), than women who are less active, according to data from the Iowa Women's Health Study published in the Dec. 11/25 issue of the Archives of Internal Medicine.
Aditya Bardia, MD, MPH, of the Mayo Clinic College of Medicine in Rochester, Minn., and colleagues tracked women's self-reported levels of physical activity and breast cancer incidence, including tumor status, in a cohort of 41,836 women over 18 years. Those who reported high levels of physical activity had a 14% lower risk of developing breast cancer, compared with their less-active counterparts, and a 9% lower risk of breast cancer after researchers controlled for body mass index (BMI). This suggests that not all of the association was due to the effect of exercise on body weight. The association was strongest among women with ER? tumors. Specifically, women with high physical activity levels had a 34% lower risk of developing this type of cancer after adjusting for BMI.
"If found to be causally related to breast cancer, physical activity would have a substantial public health effect on the prevention of this disease, along with its other positive health benefits," the authors conclude.
Emerging multiplex UTI testing drives Medicare costs amid increased utilization
November 27th 2024A recent study found a sharp rise in Medicare claims for multiplex urinary tract infection testing from 2016 to 2023, underscoring a significant financial impact and the need for further research into its clinical benefits.
Read More
Reduced subsequent births reported after severe maternal morbidity
November 26th 2024Women experiencing severe maternal morbidity during their first pregnancy face significantly lower odds of subsequent births, emphasizing the need for personalized reproductive counseling and ongoing monitoring.
Read More
Maternal sFLT1 and EDN1 linked to late-onset preeclampsia
November 25th 2024A new study highlights the association of maternal soluble Fms-like tyrosine kinase 1 and endothelin 1 with preeclampsia severity, offering insights into the pathogenesis of early- and late-onset forms of the condition.
Read More
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More